Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
169.4 USD | +0.50% | +5.07% | +9.32% |
Jun. 08 | Top law firms in US opioid lawsuits to get hundreds of millions in fees | RE |
Jun. 07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.32% | 299B | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B | |
-0.73% | 162B | |
+1.53% | 123B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- BMO Capital Cuts Price Target on AbbVie to $180 From $195, Maintains Outperform Rating